Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68252ebe7a497-trace').style.display = (document.getElementById('cakeErr68252ebe7a497-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68252ebe7a497-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68252ebe7a497-code').style.display = (document.getElementById('cakeErr68252ebe7a497-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68252ebe7a497-context').style.display = (document.getElementById('cakeErr68252ebe7a497-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68252ebe7a497-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68252ebe7a497-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26504,
		&#039;title&#039; =&gt; &#039;Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 15 November, 2014, http://timesofindia.indiatimes.com/india/Top-selling-100-drugs-to-get-cheaper-soon/articleshow/45154062.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674542,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26504,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;nppa,Access to Healthcare,medicine,medicines,Health,Health Expenditure,health issues,health of women,healthcare,healthcare in india&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26504,
	&#039;title&#039; =&gt; &#039;Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 15 November, 2014, http://timesofindia.indiatimes.com/india/Top-selling-100-drugs-to-get-cheaper-soon/articleshow/45154062.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674542,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26504
$metaTitle = &#039;LATEST NEWS UPDATES | Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;
$metaKeywords = &#039;nppa,Access to Healthcare,medicine,medicines,Health,Health Expenditure,health issues,health of women,healthcare,healthcare in india&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Top-selling 100 drugs to get cheaper soon -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Top-selling 100 drugs to get cheaper soon -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.</p><p align="justify">For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.</p><p align="justify">The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.</p><p align="justify">However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.</p><p align="justify">Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.</p><p align="justify">The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.</p><p align="justify">Recently, the pricing authority conducted a detailed study that revealed presence of certain &quot;anomalies or discrepancies&quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.</p><p align="justify">The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.</p><p align="justify">According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68252ebe7a497-trace').style.display = (document.getElementById('cakeErr68252ebe7a497-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68252ebe7a497-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68252ebe7a497-code').style.display = (document.getElementById('cakeErr68252ebe7a497-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68252ebe7a497-context').style.display = (document.getElementById('cakeErr68252ebe7a497-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68252ebe7a497-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68252ebe7a497-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26504,
		&#039;title&#039; =&gt; &#039;Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 15 November, 2014, http://timesofindia.indiatimes.com/india/Top-selling-100-drugs-to-get-cheaper-soon/articleshow/45154062.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674542,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26504,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;nppa,Access to Healthcare,medicine,medicines,Health,Health Expenditure,health issues,health of women,healthcare,healthcare in india&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26504,
	&#039;title&#039; =&gt; &#039;Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 15 November, 2014, http://timesofindia.indiatimes.com/india/Top-selling-100-drugs-to-get-cheaper-soon/articleshow/45154062.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674542,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26504
$metaTitle = &#039;LATEST NEWS UPDATES | Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;
$metaKeywords = &#039;nppa,Access to Healthcare,medicine,medicines,Health,Health Expenditure,health issues,health of women,healthcare,healthcare in india&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Top-selling 100 drugs to get cheaper soon -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Top-selling 100 drugs to get cheaper soon -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.</p><p align="justify">For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.</p><p align="justify">The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.</p><p align="justify">However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.</p><p align="justify">Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.</p><p align="justify">The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.</p><p align="justify">Recently, the pricing authority conducted a detailed study that revealed presence of certain &quot;anomalies or discrepancies&quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.</p><p align="justify">The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.</p><p align="justify">According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68252ebe7a497-trace').style.display = (document.getElementById('cakeErr68252ebe7a497-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68252ebe7a497-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68252ebe7a497-code').style.display = (document.getElementById('cakeErr68252ebe7a497-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68252ebe7a497-context').style.display = (document.getElementById('cakeErr68252ebe7a497-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68252ebe7a497-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68252ebe7a497-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26504,
		&#039;title&#039; =&gt; &#039;Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 15 November, 2014, http://timesofindia.indiatimes.com/india/Top-selling-100-drugs-to-get-cheaper-soon/articleshow/45154062.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674542,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26504,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;nppa,Access to Healthcare,medicine,medicines,Health,Health Expenditure,health issues,health of women,healthcare,healthcare in india&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26504,
	&#039;title&#039; =&gt; &#039;Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 15 November, 2014, http://timesofindia.indiatimes.com/india/Top-selling-100-drugs-to-get-cheaper-soon/articleshow/45154062.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674542,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26504
$metaTitle = &#039;LATEST NEWS UPDATES | Top-selling 100 drugs to get cheaper soon -Sushmi Dey&#039;
$metaKeywords = &#039;nppa,Access to Healthcare,medicine,medicines,Health,Health Expenditure,health issues,health of women,healthcare,healthcare in india&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Recently, the pricing authority conducted a detailed study that revealed presence of certain &amp;quot;anomalies or discrepancies&amp;quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &amp;quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&amp;quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Top-selling 100 drugs to get cheaper soon -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Top-selling 100 drugs to get cheaper soon -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.</p><p align="justify">For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.</p><p align="justify">The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.</p><p align="justify">However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.</p><p align="justify">Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.</p><p align="justify">The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.</p><p align="justify">Recently, the pricing authority conducted a detailed study that revealed presence of certain &quot;anomalies or discrepancies&quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.</p><p align="justify">The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.</p><p align="justify">According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 26504,
		'title' => 'Top-selling 100 drugs to get cheaper soon -Sushmi Dey',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<em>NEW DELHI: </em>Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.
</p>
<p align="justify">
For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.
</p>
<p align="justify">
The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.
</p>
<p align="justify">
However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.
</p>
<p align="justify">
Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.
</p>
<p align="justify">
The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.
</p>
<p align="justify">
Recently, the pricing authority conducted a detailed study that revealed presence of certain &quot;anomalies or discrepancies&quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.
</p>
<p align="justify">
The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.
</p>
<p align="justify">
According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. 
</p>',
		'credit_writer' => 'The Times of India, 15 November, 2014, http://timesofindia.indiatimes.com/india/Top-selling-100-drugs-to-get-cheaper-soon/articleshow/45154062.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4674542,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 26504,
	'metaTitle' => 'LATEST NEWS UPDATES | Top-selling 100 drugs to get cheaper soon -Sushmi Dey',
	'metaKeywords' => 'nppa,Access to Healthcare,medicine,medicines,Health,Health Expenditure,health issues,health of women,healthcare,healthcare in india',
	'metaDesc' => '
-The Times of India


NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under...',
	'disp' => '<div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.</p><p align="justify">For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.</p><p align="justify">The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.</p><p align="justify">However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.</p><p align="justify">Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.</p><p align="justify">The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.</p><p align="justify">Recently, the pricing authority conducted a detailed study that revealed presence of certain &quot;anomalies or discrepancies&quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.</p><p align="justify">The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.</p><p align="justify">According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. </p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 26504,
	'title' => 'Top-selling 100 drugs to get cheaper soon -Sushmi Dey',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<em>NEW DELHI: </em>Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.
</p>
<p align="justify">
For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.
</p>
<p align="justify">
The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.
</p>
<p align="justify">
However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.
</p>
<p align="justify">
Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.
</p>
<p align="justify">
The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.
</p>
<p align="justify">
Recently, the pricing authority conducted a detailed study that revealed presence of certain &quot;anomalies or discrepancies&quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.
</p>
<p align="justify">
The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.
</p>
<p align="justify">
According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. 
</p>',
	'credit_writer' => 'The Times of India, 15 November, 2014, http://timesofindia.indiatimes.com/india/Top-selling-100-drugs-to-get-cheaper-soon/articleshow/45154062.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'top-selling-100-drugs-to-get-cheaper-soon-sushmi-dey-4674542',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4674542,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {},
		(int) 6 => object(Cake\ORM\Entity) {},
		(int) 7 => object(Cake\ORM\Entity) {},
		(int) 8 => object(Cake\ORM\Entity) {},
		(int) 9 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 26504
$metaTitle = 'LATEST NEWS UPDATES | Top-selling 100 drugs to get cheaper soon -Sushmi Dey'
$metaKeywords = 'nppa,Access to Healthcare,medicine,medicines,Health,Health Expenditure,health issues,health of women,healthcare,healthcare in india'
$metaDesc = '
-The Times of India


NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under...'
$disp = '<div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists.</p><p align="justify">For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules.</p><p align="justify">The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context.</p><p align="justify">However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states.</p><p align="justify">Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption.</p><p align="justify">The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales.</p><p align="justify">Recently, the pricing authority conducted a detailed study that revealed presence of certain &quot;anomalies or discrepancies&quot; in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM.</p><p align="justify">The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. &quot;Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability,&quot; says D G Shah, secretary general, Indian Pharmaceutical Alliance.</p><p align="justify">According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers. </p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Top-selling 100 drugs to get cheaper soon -Sushmi Dey

-The Times of India NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists. For instance, currently only one strength of Paracetamol is under price control, whereas NPPA has proposed to cap prices of all brands of the medicine as listed in the Indian Pharmacopeia. Similarly, in case of Nelfinavir and Ritonavir, commonly used antiretrovirals in treatment of HIV, the regulator plans to fix prices of tablets along with capsules. The move is significant because this is the second time NPPA has attempted to slash prices of drugs that are outside the National List of Essential Medicines (NLEM), 2011. In May, the pricing authority had invoked a public interest clause to reduce prices of 108 medicines. However, it had to withdraw the guidelines after companies approached court and the law ministry opined that using the clause may be out of context. However, official sources say, this time there is political consensus on the issue, mainly ahead of upcoming assembly elections in some states. Currently, the government regulates prices of only 348 medicine formulations or 652 packs as listed in the NLEM. However, the list includes only specific dosages, strengths and combinations of medicine formulation. The regulator is of the view that this loophole does not ensure price regulation of all life saving and essential medicines of mass consumption. The latest move of NPPA is aimed at expanding the span of price control to include medicines dosages, strengths and combinations which are commonly used and have high market share in terms of sales. Recently, the pricing authority conducted a detailed study that revealed presence of certain "anomalies or discrepancies" in specification or description in the NLEM 2011. Following the findings of the study conducted across the country, the NPPA has proposed rectification in the NLEM. The move has created a stir among pharmaceutical companies who are concerned about stressed margins as well as instability promoted through such periodic price changes. "Mass consumption is not a criterion for NLEM. It would be desirable that the selection of drugs is left to the core committee of experts as per the established criteria. The role of the NPPA is to implement the policy in letter and spirit and not create confusion leading to instability," says D G Shah, secretary general, Indian Pharmaceutical Alliance. According to a senior official in the department of pharma, the proposal for changes in the list of essential medicines has been sent to the health ministry which has the ultimate authority to revise the same. Besides, NPPA has also sought comments from other stakeholders such as patient groups and drug manufacturers.